Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-11 Sale | 2024-03-12 9:45 pm | Cidara Therapeutics Inc. | CDTX | Shah Preetam CFO & CBO | 18,931 | $0.6698 | $12,680 | 227,210 (Direct) | View |
| 2023-03-13 Sale | 2023-03-13 9:20 pm | Cidara Therapeutics Inc. | CDTX | Shah Preetam CFO & CBO | 6,648 | $1.53 | $10,171 | 148,141 (Direct) | View |
| 2022-09-19 Sale | 2022-09-19 8:28 pm | Cidara Therapeutics Inc. | CDTX | Shah Preetam CFO & CBO | 15,642 | $0.7694 | $12,035 | 150,789 (Direct) | View |
| 2021-11-12 Purchase | 2021-11-15 6:38 pm | Cidara Therapeutics Inc. | CDTX | Shah Preetam CFO & CBO | 20,000 | $1.54 | $30,800 | 20,000 (Direct) | View |
| 2019-12-24 Purchase | 2019-12-27 07:01 am | BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Shah Preetam EVP, CFO and Treasurer | 11,600 | $3.9594 | $45,929 | 36,600 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-09-30 Option Award | 2024-10-02 5:19 pm | N/A 2034-09-29 | Cidara Therapeutics Inc. | CDTX | Shah Preetam Chief Financial Officer | 130,087 | $0 | 130,087 (Direct) | View |
| 2024-03-15 Option Award | 2024-03-20 6:48 pm | N/A 2034-03-14 | Cidara Therapeutics Inc. | CDTX | Shah Preetam CFO & CBO | 326,250 | $0 | 553,460 (Direct) | View |
| 2023-03-27 Option Award | 2023-03-29 5:24 pm | N/A 2033-03-26 | Cidara Therapeutics Inc. | CDTX | Shah Preetam CFO & CBO | 270,000 | $0 | 418,141 (Direct) | View |
| 2022-09-15 Exercise | 2022-09-19 8:28 pm | N/A 2022-09-30 | Cidara Therapeutics Inc. | CDTX | Shah Preetam CFO & CBO | 50,000 | $0 | 150,789 (Direct) | View |
| 2022-03-31 Tax Withholding | 2022-04-04 5:21 pm | N/A N/A | Cidara Therapeutics Inc. | CDTX | Shah Preetam CFO & CBO | 24,820 | $0.83 | 214,931 (Direct) | View |
| 2022-03-31 Option Award | 2022-04-04 5:21 pm | N/A 2032-03-30 | Cidara Therapeutics Inc. | CDTX | Shah Preetam CFO & CBO | 219,751 | $0 | 214,931 (Direct) | View |
| 2021-09-01 Option Award | 2021-09-03 4:32 pm | N/A 2031-08-31 | Cidara Therapeutics Inc. | CDTX | Shah Preetam CFO & CBO | 361,850 | $0 | 361,850 (Direct) | View |
| 2020-12-30 Tax Withholding | 2020-12-31 9:20 pm | N/A N/A | BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Shah Preetam EVP, CFO and Treasurer | 25,000 | $4.64 | 11,600 (Direct) | View |